Le Lézard
Classified in: Health, Science and technology
Subjects: Conference, Trade Show, Webcast

scPharmaceuticals Inc. to Present at the Piper Jaffray 31st Annual Healthcare Conference


scPharmaceuticals Inc. (Nasdaq: SCPH), a pharmaceutical company focused on developing and commercializing products that have the potential to optimize the delivery of infused therapies, advance patient care, and reduce healthcare costs, today announced that John Tucker, chief executive officer, will present and host investor meetings at the Piper Jaffray 31st Annual Healthcare Conference being held at the Lotte New York Palace in New York, NY. The Company is scheduled to present on Thursday, December 5, 2019, at 8:50 a.m. ET.

A live webcast of the presentation can be accessed under "News & Events" in the Investor Relations section of the Company's website, www.scpharmaceuticals.com, and will be archived for ninety days.

About scPharmaceuticals
scPharmaceuticals is a pharmaceutical company focused on developing and commercializing products that are designed to reduce healthcare costs and improve health outcomes. The Company develops, internally and through strategic partnerships, innovative products and solutions that aim to expand and advance the outpatient care of select acute conditions. The Company's lead programs focus on the subcutaneous, self-administration of IV-strength treatments in heart failure and infectious disease. scPharmaceuticals is headquartered in Burlington, MA. For more information, please visit scPharmaceuticals.com.


These press releases may also interest you

at 09:05
Aspen Technology Introduces New Strategic Planning for Sustainability Pathways Solution
Aspen Technology, Inc. , a global leader in industrial software, today introduced AspenTech Strategic Planning for Sustainability Pathwaystm ? a new and unique integrated modelling and optimization solution that aims to guide companies in carbon...

at 09:00
Known for Affordable Oral Health Care, Dental Care Acworth is Offering a New High-Tech AI Dental Patient Experience
Dental Care Acworth is thrilled to utilize this remarkable innovation and offer patients unbiased, objective and standardized dental care that they know they can trust. The AI solutions Pearl delivers can assist dental...

at 09:00
Introducing Ceph Squid: The Future of Storage Today, Reinforced by Strongest Alliance Yet
The Ceph Foundation, the global community dedicated to fostering the growth and advancement of Ceph, is excited to announce the release of Ceph Squid, which comes with several performance and space efficiency features along with enhanced protocol...

at 09:00
AMGEN TO SUBMIT TEPROTUMUMAB MARKETING AUTHORIZATION APPLICATION TO THE EUROPEAN MEDICINES AGENCY
Amgen today announced the imminent submission of a Marketing Authorization Application (MAA) to the European Medicines Agency (EMA) for teprotumumab, a fully human monoclonal antibody and targeted inhibitor of the insulin-like growth factor-1...

at 09:00
RapidScale Partners with Proficio to Offer SOC as a Service (SOCaaS) Delivering Advanced Threat Protection for Customers
RapidScale, a Cox Business company, bolsters its cybersecurity offerings with SOC as a Service that includes Managed Detection and Response (MDR), a cutting-edge security solution powered by Proficio. This strategic partnership reinforces...

at 09:00
Ractigen Therapeutics Announces FDA Approval for RAG-01, a First-in-Class saRNA Therapy for BCG-Unresponsive NMIBC
Ractigen Therapeutics, a leader in the development of small activating RNA (saRNA) therapeutics, announced today that the U.S. Food and Drug Administration (FDA) has approved the company's Investigational New Drug (IND) application for RAG-01, a...

More news about Science and technology...


News published on and distributed by: